The women’s health market is growing at a compound annual growth rate of 12.5%, projected to reach $24.5 billion in 2027. This growth will be fueled by innovation and new partnerships to break down the barriers and address many of the significant unmet medical needs that women face.
Join this panel of leaders to hear where groundbreaking work is being done today, where real progress is still needed, and how the life sciences ecosystem can address the lack of innovation and build a strong and sustainable market for women’s health.
The discussion will bring a sharp focus on the significant health needs women still face, and the correspondingly dismal underfunding and under prioritization of women’s health and innovation. For example, only 4% of all healthcare research and development is focused on women’s health, which leaves half the population behind the curve of health innovation. However, there is new and potentially exciting research in the pipeline, and opportunities across pharmaceuticals, devices and technology, that could accelerate growth and be a catalyst for progress which will have a significant impact on healthcare in general.